Merck Wins FDA Nod for RSV Antibody, Tees Up Challenge to Sanofi, AstraZeneca
Merck’s Enflonsia will go up against Sanofi and AstraZeneca’s Beyfortus, which the partners plan to ship out early in the third quarter.
Merck Wins FDA Nod for RSV Antibody, Tees Up Challenge to Sanofi, AstraZeneca Read More »
